These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3953430)

  • 21. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
    White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of slow-release verapamil on blood pressure and cardiovascular system in essential hypertension.
    Meric M; Adalet K; Erzengin F; Korkut F; Okur O; Büyüköztürk K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S42-4. PubMed ID: 2475684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press.
    Libretti A; Catalano M
    Drugs; 1993; 46 Suppl 2():16-23. PubMed ID: 7512469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrochlorothiazide and verapamil in the treatment of hypertension. The Verapamil Versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S33-7. PubMed ID: 1725915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparisons of verapamil administration twice and three times daily in hypertension.
    Salmela PI; Gordin A; Salo H; Ottoila P; Jounela AJ
    Ann Clin Res; 1988; 20(3):195-200. PubMed ID: 3058014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of 'once daily' verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording.
    Caruana M; Heber M; Brigden G; Raftery EB
    Eur J Clin Pharmacol; 1987; 32(6):549-53. PubMed ID: 3653223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension.
    Frishman WH; Eisen G; Charlap S; Strom JA
    J Clin Hypertens; 1987 Dec; 3(4):605-9. PubMed ID: 3134517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.
    Weir MR; Cassidy CA; Hall PS; Lancaster A; Schubert C; Urick A; Saunders E; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1990; 12(2):139-48. PubMed ID: 2354483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Instant and sustained-release verapamil in the treatment of essential hypertension.
    Midtbø K; Hals O; van der Meer J; Storstein L; Lauve O
    Am J Cardiol; 1986 Feb; 57(7):59D-63D. PubMed ID: 3513516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive blood pressure monitoring evaluation of verapamil slow-release 240-mg antihypertensive effectiveness.
    Novo S; Alaimo G; Abrignani MG; Longo B; Muratore G; Strano A
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S38-41. PubMed ID: 2475683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination of verapamil and captopril in the treatment of essential hypertension.
    Heagerty AM; Swales JD
    Pharmatherapeutica; 1987; 5(1):21-5. PubMed ID: 3299395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sustained-released verapamil and ambulatory recording of blood pressure in mild to moderate essential hypertension].
    Bernadet P; Suc JM; Durand D; Galey C; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1992 Feb; 41(2):105-12. PubMed ID: 1562157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive effect of verapamil in patients with newly discovered mild to moderate essential hypertension.
    Hedbäck B; Hermann LS
    Acta Med Scand Suppl; 1984; 681():129-35. PubMed ID: 6587751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of verapamil on home self-measurement of blood pressure and heart rate by hypertensive patients. Verapamil-Frequency Research Group.
    Fernández-González R; Gómez-Pajuelo C; Gabriel R; de La Figuera M; Moreno E; of The Verapamil-Frequency Res
    Blood Press Monit; 2000 Feb; 5(1):23-30. PubMed ID: 10804447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group.
    Scholze J; Zilles P; Compagnone D
    Br J Clin Pharmacol; 1998 May; 45(5):491-5. PubMed ID: 9643623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of verapamil and beta blockers in systemic hypertension.
    Dargie H; Cleland J; Findlay I; Murray G; McInnes G
    Am J Cardiol; 1986 Feb; 57(7):80D-82D. PubMed ID: 3513518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
    Veratran Study Group
    Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of prazosin and verapamil in the treatment of essential hypertension.
    Elliott HL; Meredith PA; Campbell L; Reid JL
    Clin Pharmacol Ther; 1988 May; 43(5):554-60. PubMed ID: 3284690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.